People: Cynosure Inc (CYNO.OQ)

CYNO.OQ on NASDAQ Stock Exchange Global Select Market

25.29USD
24 May 2013
Price Change (% chg)

$0.25 (+1.00%)
Prev Close
$25.04
Open
$24.96
Day's High
$25.50
Day's Low
$24.69
Volume
61,338
Avg. Vol
57,661
52-wk High
$30.19
52-wk Low
$18.39

Search Stocks

Summary

Name Age Since Current Position

Michael Davin

54 2004 Chairman of the Board, President, Chief Executive Officer

Timothy Baker

51 2004 Chief Financial Officer, Executive Vice President, Treasurer

Douglas Delaney

45 2005 Executive Vice President - Sales

Andrea Cangioli

46 2002 Director

Brian Barefoot

69 2011 Independent Director

Ettore Biagioni

54 2005 Independent Director

Marina Hatsopoulos

46 2008 Independent Director

Thomas Robinson

53 2005 Independent Director

Biographies

Name Description

Michael Davin

Mr. Michael R. Davin is the Chairman of the Board, President, Chief Executive Officer of Cynosure Inc. Mr. Davin has been the president and chief executive officer and a director since September 2003, and became the chairman of the board of directors in October 2004. Mr. Davin has over 25 years of experience in the light-based technology field. From 1998 to 2003, Mr. Davin served as co-founder and vice president of worldwide sales and strategic development of Cutera, Inc., a provider of laser and other light-based aesthetic treatment systems. Prior to co-founding Cutera, Mr. Davin spent 11 years at Coherent Medical, Inc., a manufacturer of laser, optics and related equipment, in senior management positions in sales, marketing and clinical development.

Timothy Baker

Mr. Timothy W. Baker is Executive Vice President, Chief Financial Officer and Treasurer of Cynosure Inc. Mr. Baker has been the executive vice president, chief financial officer and treasurer since March 2004. From July 2003 to February 2004, Mr. Baker served as vice president, finance of Stryker Biotech, a division of Stryker Corporation, a medical products and services provider. From July 2000 to June 2003, Mr. Baker served as president and chief financial officer of Photoelectron Corp., a provider of miniature x-ray systems for radiation therapy. From January 1996 to July 2000, Mr. Baker served as the chief financial officer and vice president of operations of Radionics, Inc., a provider of surgical devices. Mr. Baker is a certified public accountant and holds an M.B.A. in operations management.

Douglas Delaney

Mr. Douglas J. Delaney is Executive Vice President - Sales of Cynosure Inc. Mr. Delaney has been the executive vice president, sales since February 2005 and has worked in medical laser sales for more than 16 years. From May 2004 until February 2005, Mr. Delaney was the vice president, North American sales, and from September 2003 until May 2004, he was the director of North American sales. From September 1999 to September 2003, Mr. Delaney served as national sales manager of Cutera.

Andrea Cangioli

Mr. Andrea Cangioli is Director of Cynosure Inc. Mr. Cangioli has been a director since 2002. Mr. Cangioli has served as a director and the general manager of the Selling Stockholder since 1992. Mr. Cangioli also serves on the boards of other companies affiliated with the Selling Stockholder.

Brian Barefoot

Mr. Brian M. Barefoot is the Independent Director of Cynosure Inc. From 2001 to 2008, Mr. Barefoot has been a director since 2011. From 2001 to 2008, Mr. Barefoot served as Babson College president. From 1996 to 2001, Mr. Barefoot served as chairman of the board of trustees of Babson College. Mr. Barefoot serves on the boards of directors of Blue Cross Blue Shield of Massachusetts, where he is Chair of the Finance and Business Performance Committee and a member of the audit committee. Mr. Barefoot serves as a director of Array Health Solutions, Inc., a health care technology and services company based in Seattle, and as a director of BigBelly Solar, a manufacturer of solar-powered trash compactors. Mr. Barefoot is a senior advisor to Carl Marks & Co. LP, a New York-based middle market merchant bank.

Ettore Biagioni

Mr. Ettore V. Biagioni is the Independent Director of Cynosure Inc. He has been a director since 2005. Since 2004, Mr. Biagioni has been a managing partner of Alothon Group LLC, a private equity firm which he co-founded. From 1998 to 2004, Mr. Biagioni served as head of the Latin America Private Equity Group of Deutsche Bank/Bankers Trust Company. Mr. Biagioni serves on the boards of directors of several private companies.

Marina Hatsopoulos

Ms. Marina Hatsopoulos is Independent Director of Cynosure Inc. Ms. Hatsopoulos has been a private investor since September 2007. From August 2005 to September 2007, she was a director of Contex Holdings, a manufacturer of format scanners. From December 1994 to August 2005, she served as chief executive officer and director of Z Corporation, a in the 3D printing market, which was sold to Contex Scanning Technology in 2005. From 2005 through 2010, Ms. Hatsopoulos served as a director of the GSI Group Inc., a supplier of precision technology to the global medical, electronics and industrial markets and semiconductor systems. From 2007 through its sale to Sara Lee in 2011, Ms. Hatsopoulos was as a director and investor of Tea Forte, a supplier of luxury tea products. In 2008, Ms. Hatsopoulos became a founding member of the Advisory Board of the Deshpande Center for Technological Innovation at MIT. Ms. Hatsopoulos has experience serving as a director and advisor for both public and private companies, which enhances her contributions to the board.

Thomas Robinson

Mr. Thomas H. Robinson is Independent Director of Cynosure Inc. Since September 2011, Mr. Robinson has served as a partner with RobinsonButler, an executive search firm. In 2010, Mr. Robinson served as managing director at Russell Reynolds Associates. From 1998 to 2010, Mr. Robinson served as managing partner of the North American medical technology practice, which includes the medical device, hospital supply/distribution and medical software areas, of Spencer Stuart, Inc., a global executive search firm. From 2002 to 2010, Mr. Robinson had been a member of Spencer Stuart’s board services practice, which assists corporations to identify and recruit outside directors. From 1998 to 2000, Mr. Robinson headed Spencer Stuart’s North American biotechnology specialty practice. From 1993 to 1997, Mr. Robinson served as president of the emerging markets business at Boston Scientific Corporation, a global medical devices manufacturer. From 1991 to 1993, Mr. Robinson also served as president and chief operating officer of Brunswick Biomedical, a cardiology medical device company. In 2009, Mr. Robinson became a director of SANUWAVE Health, Inc., a publicly-traded regenerative medicine company, through its reverse merger with Rub Music Enterprises, Inc.

Basic Compensation

Name Fiscal Year Total

Michael Davin

1,853,860

Timothy Baker

1,101,030

Douglas Delaney

903,614

Andrea Cangioli

--

Brian Barefoot

--

Ettore Biagioni

--

Marina Hatsopoulos

--

Thomas Robinson

--
As Of 30 Dec 2011

Options Compensation

Name Options Value

Michael Davin

551,365 9,888,510

Timothy Baker

265,311 4,759,018

Douglas Delaney

284,065 5,093,963

Andrea Cangioli

0 0

Brian Barefoot

0 0

Ettore Biagioni

0 0

Marina Hatsopoulos

0 0

Thomas Robinson

0 0
Search Stocks